key: cord-0874395-46evycyn
authors: Bojkova, Denisa; Wagner, Julian U. G.; Shumliakivska, Mariana; Aslan, Galip S.; Saleem, Umber; Hansen, Arne; Luxán, Guillermo; Günther, Stefan; Pham, Minh Duc; Krishnan, Jaya; Harter, Patrick N.; Ermel, Utz; Frangakis, Achilleas; Zeiher, Andreas M.; Milting, Hendrik; Cinatl, Jindrich; Dendorfer, Andreas; Eschenhagen, Thomas; Ciesek, Sandra; Dimmeler, Stefanie
title: SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes
date: 2020-06-01
journal: bioRxiv
DOI: 10.1101/2020.06.01.127605
sha: f07bb909a56f7a8219b8ee7607cbc7d6a694504d
doc_id: 874395
cord_uid: 46evycyn

Background The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has emerged as global pandemic. SARS-CoV-2 infection can lead to elevated markers of cardiac injury associated with higher risk of mortality in COVID-19 patients. It is unclear whether cardiac injury may have been caused by direct infection of cardiomyocytes or is mainly secondary to lung injury and inflammation. Here we investigate whether human cardiomyocytes are permissive for SARS-CoV-2 infection. Methods Infection was induced by two strains of SARS-CoV-2 (FFM1 and FFM2) in human induced pluripotent stem cells-derived cardiomyocytes (hiPS-CM) and in two models of human cardiac tissue. Results We show that SARS-CoV-2 infects hiPS-CM as demonstrated by detection of intracellular double strand viral RNA and viral spike glycoprotein protein expression. Increasing concentrations of virus RNA are detected in supernatants of infected cardiomyocytes, which induced infections in CaCo-2 cell lines documenting productive infections. SARS-COV-2 infection induced cytotoxic and pro-apoptotic effects and abolished cardiomyocyte beating. RNA sequencing confirmed a transcriptional response to viral infection as demonstrated by the up-regulation of genes associated with pathways related to viral response and interferon signaling, apoptosis and reactive oxygen stress. SARS-CoV-2 infection and cardiotoxicity was confirmed in a iPS-derived human 3D cardiosphere tissue models. Importantly, viral spike protein and viral particles were detected in living human heart slices after infection with SARS-CoV-2. Conclusions The demonstration that cardiomyocytes are permissive for SARS-CoV-2 infection in vitro warrants the further in depth monitoring of cardiotoxic effects in COVID-19 patients. Clinical Perspective What is New? This study demonstrates that human cardiac myocytes are permissive for SARS-CoV-2 infection. The study documents that SARS-CoV-2 undergoes a full replicatory circle and induces a cytotoxic response in cardiomyocytes. Infection was confirmed in two cardiac tissue models, including living human heart slices. What are the Clinical Implications? The study may provide a rational to explain part of the cardiotoxicity observed in COVID-19 patients The demonstration of direct cardiotoxicity induced by SARS-CoV-2 warrants an in depth further analysis of cardiac tissue of COVID-19 patients and a close monitoring for putative direct cardiomyocyte injury. The established models can be used to test novel therapeutic approaches targeting COVID-19.

The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has emerged as global pandemic. SARS-CoV-2 mainly invades alveolar epithelial cells and causes adult respiratory distress syndromes. COVID-19 is associated with myocardial injury, as assessed by increased troponin T and NT-proBNP levels accompanying increased cardiovascular symptoms in a significant number of SARS-CoV-2 infected patients 1, 2 . Elevated levels of cardiac injury markers were associated with higher risk of in-hospital mortality in COVID-19 patients 3 . In patients showing clinical deterioration during COVID-19, left ventricular systolic dysfunction was noted in approximately 20 % of patients according to a most recent study 4 . In addition, patients with underlying cardiovascular disease represent a significant proportion of patients, who may suffer from severe courses after COVID-19 infections 5 . However, it is unclear whether elevated biomarkers of cardiac injury and long term effects on the cardiovascular system are directly caused by viral infection of cardiac tissue or are secondary to hypoxia and systemic inflammation during complicated COVID-19 courses. Earlier studies with cardiac tissue samples did not find evidence for viral particles of the first SARS corona virus SARS-CoV 6 , but other studies suggest that the Middle East respiratory syndrome-related coronavirus (MERS-CoV), which has similar pathogenicity as SARS-CoV-2, can cause acute myocarditis and heart failure 7 . Moreover, substantial amounts of viral SARS-CoV-2 RNA was detected in human hearts of COVID-19 patients 8 .

Single cell RNA sequencing and histological analyses demonstrated that human cardiomyocytes express the putative SARS-CoV-2 receptor angiotensin converting enzyme 2 (ACE2), particularly in patients with cardiovascular diseases 9,10 suggesting that cardiomyocytes could be targeted by SARS-CoV-2.

Therefore, we investigated whether SARS-CoV-2 infects human induced pluripotent stem cell-derived cardiomyocytes in culture and in two models of human cardiac tissue including human heart slices in vitro. 5 

Cell Culture hiPS-CM of two donors were obtained with an embryoid body-based protocol as described 11 .

Cardiospheres were generated by adapting a previously described protocol 12 using hiPS cells.

Living human heart slices (300 µm) were generated and cultured as described 9

Viral infection SARS-CoV-2-FFM1 and FFM2 were isolated and propagated in Caco-2 cells as described 13, 14 . The viral stock was diluted to desired MOI in medium containing 1% fetal bovine serum and incubated with cells for 2 h. Then the infectious inoculum was removed and cells were supplemented with the respective culture medium 11 . Cardiospheres were cultured with 25µl of viral stock (1.10 7 TCID50/ml) and living human heart slices were incubated with 200µl of viral stock (1.10 7 TCID50/ml) for three to five days.

Quantification of SARS-CoV RNA in cell culture supernatants was performed as previously 

We first addressed if human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CM) showed the expression of the SARS-CoV-2 receptors ACE2 and the serine proteases TMPRSS2 and cathepsins, which mediate priming of the viral S-protein 15 . ACE2 and cathepsins CTSB and CTSL were well expressed on mRNA level in hiPS-CM, whereas TMPRSS2 was detected only at very low levels by RNA sequencing (Figure 1a) .

Quantitative RT-PCR confirmed the expression of ACE2, but TMPRSS2 was below the detection level (Figure 1b) . ACE2 protein expression was confirmed by immunostainings (Figure 2k) . and augmented apoptosis in hiPS-CM (Figure 2l) .

Interestingly, the frequency of beating was significantly augmented at 24h to 48h post infection, but was abolished at later time points (Figure 2m) . Profound cytopathogenic effects were visible at later time points (96 h) (Figure 2h) . RNA sequencing demonstrated that infected hiPS-CM showed a strong transcriptional response to viral infection including interferon activation (Figure 2n ) and signatures of apoptosis and oxidative stress (Figure 2o) .

Next, we determined if SARS-CoV-2 infects cardiomyocytes in a three dimensional tissue environment using human cardiospheres generated by hiPS-cells, which are generated by a 7 modified previously published protocol 12 (Figure 3a-b) . SARS-CoV-2 time-dependently affected beating frequency of cardiospheres with a profound inhibition at 5 days post infection (Figure 3c) . At 5 days post infection, cardiospheres showed a reduced size (Figure 3d) consistent with the induction of cell death. SARS-CoV-2 infection was further documented by spike protein staining (Figure 3d) .

Finally, we addressed whether SARS-CoV-2 infects human heart tissue by using living human cardiac tissue slices, which were obtained from explanted hearts 16 (Figure 4a-f) . Here, increased spike protein expression was shown in four different samples derived from three donors (Figure 4c-e) . Infection was associated with morphological signs of tissue injury such as areas with loss of α-saromeric actinin signal and disorganized structure compared to homogenous mock controls (Figure 4c) . Spike protein expression was detected in asacromeric actinin positive cardiomyocytes (Figure 4d) . The virus was further identified in infected human heart tissue in cardiomyocytes by electron microscopy (Figure 4f) . Of note, stages of the entire replicatory cycle were detected (Figure 4f , right panel) 8 

Together, SARS-CoV-2 can infect human cardiomyocytes in culture as well as in two different models of cardiac tissue. Infection was documented by various read outs including intracellular viral double strand RNA and spike protein expression, as well as extracellular viral RNA. The virus was further detected by electron microscopy in cells of the infected human heart slices. Importantly, functional virus could be isolated in supernatants of infected cardiomyocytes documenting that SARS-CoV-2 undergoes a full replicatory cycle. Of note, viral infection was confirmed with cells of two different hiPS-donors and two viral strains.

Whereas the receptor ACE2 was well expressed on mRNA and protein level, the previously described protease activator TMPRSS2 was very lowly expressed in hiPS-CM, suggesting that activation of the S-protein may be mediated by other serine proteases such as cathepsins, which also can mediate viral activation 15 RNA copies / mL (log 10 ) 

SARS-CoV-2: a potential novel etiology of fulminant myocarditis

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan

The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) -a Systematic Echocardiographic Study

Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases

Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus

Multiorgan and Renal Tropism of SARS-CoV-2

Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts

The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

Differentiation of cardiomyocytes and generation of human engineered heart tissue

Dissection of heterocellular cross-talk in vascularized cardiac tissue mimetics

Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan

SARS-CoV-2 infected host cell proteomics reveal potential therapy targets

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Long-term functional and structural preservation of precision-cut human myocardium under continuous electromechanical stimulation in vitro

What is the role of ER stress in the heart? Introduction and series overview

The authors thank Tatjana Starzetz (Neurological Institute (Edinger Institute), University Frankfurt) as well as Marion Basoglu (Biological Sciences, University Frankfurt) for EM Sample Preparation.

The study has been supported by the German Center for Cardiovascular Research (DZHK) and the Excellence Strategy Program of the DFG (Exc 2026).

The authors have nothing to disclose